A Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants

Clinical trial NCT05362045 · COMPLETED

Trial details

NCT number: NCT05362045
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2022-05-16
Primary completion: 2022-08-19
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.